View Clinical Trial (Medical Research Study)

Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions? - NCT00853073-19107(Clinical Trial 275026)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Philadelphia
State:  
PA
Zip Code: 19107
Conditions: Glaucoma
Purpose: The purpose of this study is to see if a new add on (or adjunctive) therapy used in glaucoma surgery improves the success of needle bleb revisions.
Study summary: To investigate the efficacy of needle bleb revisions with mitomycin C with subconjunctival bevacizumab in promoting both filtering success and favorable bleb morphologic features.
Criteria: Inclusion Criteria: - require glaucoma bleb needle revision with Mitomycin-C Exclusion Criteria: - pregnant, nursing, or not using adequate contraception - other glaucoma eye surgery involving tube shunts - prior retinal detachments surgery with scleral buckle - infection, inflammation, or any abnormality preventing eye pressure measurement - enrolled in another investigational study
Study is available at: Wills Eye Institute, Glaucoma Service
Philadelphia, PA 19107
United States

Primary Contact:
Sheryl Wizov, COA
Phone: 215-928-3221

Secondary Contact:
Sheryl Wizov, COA
Email: swizov@willseye.org
Phone: 215-928-3221
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.